Cargando…
MicroRNAs as regulators of metabolic disease: pathophysiologic significance and emerging role as biomarkers and therapeutics
The prevalence of overweight and obesity in developed and developing countries has greatly increased the risk of insulin resistance and type 2 diabetes mellitus. It is evident from human and animal studies that obesity alters microRNA (miRNA) expression in metabolically important organs, and that mi...
Autor principal: | Deiuliis, J A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4722234/ https://www.ncbi.nlm.nih.gov/pubmed/26311337 http://dx.doi.org/10.1038/ijo.2015.170 |
Ejemplares similares
-
MicroRNAs and long non-coding RNAs in the pathophysiological processes of diabetic cardiomyopathy: emerging biomarkers and potential therapeutics
por: Jakubik, Daniel, et al.
Publicado: (2021) -
Emerging Roles of microRNAs as Biomarkers and Therapeutic Targets for Diabetic Neuropathy
por: Fan, Baoyan, et al.
Publicado: (2020) -
The role of microRNAs in neurobiology and pathophysiology of the hippocampus
por: Rashidi, Seyed Khalil, et al.
Publicado: (2023) -
MicroRNAs in peripheral artery disease: potential biomarkers and
pathophysiological mechanisms
por: Ring, Andrew, et al.
Publicado: (2022) -
The Emerging Role of MicroRNAs in Bone Diseases and Their Therapeutic Potential
por: Bravo Vázquez, Luis Alberto, et al.
Publicado: (2021)